The full-length normal and T24 mutant human H-ras proteins and two truncated derivatives of the T24 mutant were expressed efficiently in Eschenchia coli. The proteins accumulated to 1 to 5% of total cellular protein, and each was specifically recognized by anti-ras monoclonal antibodies. The two full-length proteins as well as a carboxyl-terminal truncated derivative (deleted for 23 amino acid residues) were soluble upon cell lysis and were purified to 90% homogeneity without the use of denaturants. In contrast, an amino-terminal truncated ras derivative (deleted for 22 amino acid residues) required treatment with urea for its solubilization. The guanine nucleotide binding activity of these four proteins was assessed by a combination of ligand binding on proteins blots, immunoprecipitation, and standard filter binding procedures. The full-length proteins showed similar binding kinetics and a stoichiometry approaching 1 mol of GTP bound per mol of protein. The carboxyl-terminal truncated protein also bound GTP, but to a reduced extent, whereas the amino-terminal truncated protein did not have binding activity. Apparently, the carboxyl-terminal domain of ras, although important for transforming function, does not play a critical role in GTP binding.
The three members of the human ras gene family cH-ras-1, cK-ras-2, and N-ras encode highly related proteins of 188 to 189 amino acid residues (p21) (3, 19, 21, 31, 37) . Both qualitative and quantitative alterations in these gene products have been implicated in tumorigenesis in animals. In particular, mutant alleles of these genes which carry point changes altering amino acid residue 12 or 61 are found in a variety of tumors and tumor cell lines and, in addition, cause cellular transformation when introduced into NIH 3T3 fibroblasts (7, 10, 23, 25, 26, 29, 36, 38, 43) . Likewise, elevated expression of apparantly normal ras genes is observed in a spectrum of primary tumors (32, 33) and also may cause transformation of rodent fibroblasts (4) . The ras proteins are synthesized in the cytoplasm and subsequently localize to the inner plasma membrane (9, 20, 30, 41) . They appear to undergo posttranslational modification(s) which includes acylation (28) and results in alteration of their polyacrylamide gel electrophoretic mobility (11, 20, 30) . The ras proteins selectively bind certain guanine nucleotides (27) and recently have been shown to hydrolyze GTP to GDP and Pi (13, 18, 35) . This GTPase activity is severely impaired in products of transforming ras genes, and this deficiency may be responsible for the transforming activity of these ras genes.
Detailed biochemical and physical analyses of the ras proteins have been limited by the low levels of these proteins produced and obtainable from mammalian cells. One approach to circumvent these limitations has been to express the ras proteins in Escherichia coli. Several reports have described the expression in E. coli of v-ras fusion proteins, in which the ras polypeptide is fused to some portion of a procaryotic or synthetically derived sequence (12, 16, 34) . Often the proteins made in this way are found to be insoluble, and the use of strong denaturants has been required to obtain them in a soluble form. A recent report describes the expression of nonfused authentic ras proteins * Corresponding author. in E. coli (14) . These proteins also were produced in an insoluble form and required treatment with urea or guanidine hydrochloride for their solubilization. Both fusion proteins and proteins which have been treated with strong denaturants may prove unacceptable for detailed analysis of their protein structure, modification, function, or a combination of these.
In this report, we describe the efficient expression and purification of an E. coli-synthesized, authentic, human wild-type ras gene product and three mutant ras derivatives. These include the T24 bladder carcinoma-derived ras variant as well as an amino-terminal truncated and a carboxyl-terminal truncated derivative of the T24 protein. All four proteins are recognized by a monoclonal antibody produced against the v-H-ras gene product expressed in cells transformed with Harvey murine sarcoma virus. The normal, T24, and carboxyl-terminal truncated T24 proteins are soluble upon cell lysis and were purified without the use of chaotropic agents. All three of these proteins bind guanine nucleotides. In contrast, the amino-terminal truncated T24 protein is found to be insoluble in E. coli and exhibits no binding activity. MATERIALS igonucleotide synthesis, the silica gel solid support was obtained from Applied Biosystems, the protected nucleosides were from Cruachem Chemical Co., and all other reagents were from Aldrich Chemical Co. The hybridoma cell line producing the rat Y13-259 antibody directed against Harvey murine sarcoma virus p21 (11) was kindly provided by Mark Furth. Antibody was recovered from serum-free culture supernatants by ammonium sulfate precipitation. Synthesis of oligonucleotide linkers. The linkers used in the plasmid constructions ( Fig. 1 ) were synthesized on a silica gel polymer support (Fractosil) by the phosphite-triester procedure previously described (39) with some modifications. The solution containing the active phosphorylating derivative of the incoming nucleoside was passed through a column packed with derivatized silica gel to produce the coupled phosphite intermediate which was then oxidized to the phosphate form with aqueous iodine. The unreacted 5'-OH group was capped with a mixture of acetic anhydride, pyridine, and 4-dimethylaminopyridine. The dimethoxytrityl group was removed with 3% trichloroacetic acid in methylene chloride. After being washed with chloroform followed by pyridine, the resin was ready for the next cycle (cycle time was 15 min). At the end of the synthesis, the resin was removed from the column and treated with concentrated ammonium hydroxide to cleave the oligomer from the resin and to remove the protecting groups. After centrifugation, the ammonia solution was concentrated, and the residue was dissolved in water and purified on a 20% polyacrylamide gel. The oligomer was recovered from the gel by electrophoretic elution onto Whatman DEAE-81 paper, followed by elution with 1 M triethylammonium bicarbonate (pH 8.5). The triethylammonium bicarbonate was removed by coevaporation with water, and the sample was dissolved in water. The sequence of the oligomers was verified by a modification of the Maxam and Gilbert procedure (17) . For cloning, complementary strands were mixed in an equal molar ratio in 0.01 M NaCl, heated to 65°C, and then allowed to cool to room temperature. Plasmid constructions. (i) Human H-ras cDNA plasmids. Plasmids containing the complete protein coding and 3' noncoding sequences of the human normal (pPPS3) and T24 (pPPS22) H-ras genes were constructed (not shown) by splicing together previously described cDNA (6) and genomic (38) H-ras clones. The cDNA plasmid pRS6 contains the complete protein coding region of the transforming T24 H-ras gene (valine in place of glycine at amino acid position 12) but lacks part of the 3' noncoding sequence and has an apparent non-ras sequence upstream of the ATG initiation codon (6) . The 3' region was completed by substituting a PstI fragment of PRS6 with the corresponding fragment of pRS3 (6) which contains an intact 3' untranslated region and polyadenylic acid sequence. The cDNA sequence in the resultant plasmid, pRC1, was excised at the PvilII (between codons 22 and 23) and Sall (end of the polyadenylic acid sequence) sites and inserted into the corresponding sites of pBR322 to yield pPS11. The 5' region was completed by cleaving pPS11 with PvuII and inserting a 179-base-pair (bp) PvuII fragment from the first exon of the genomic clone pT24, which carries the complete T24 variant H-ras gene on a 6.2-kilobase BamHI fragment. This PvuII fragment extends from codon 22 to 113 bp upstream of the ATG and encodes valine at position 12. The resultant plasmid pPPS22 is shown in Fig. 1 . The corresponding plasmid encoding the normal H-ras cDNA, pPPS3 ( Fig. 1 ), was obtained by inserting the 179-bp PvuII fragment from the normal H-ras gene clone pP3 (38) . This PvuII fragment encodes glycine at position 12.
(ii) pMG27N expression vector. The 5.8-kilobase expression vector pOT1 (5) was digested with EcoRI, filled in with E. coli DNA polymerase Klenow fragment, and then partially digested with BalI ( Fig. 1 ). The 5-kilobase EcoRI-BalI fragment, isolated by polyacrylamide gel electrophoresis (PAGE) and electroelution, was incubated overnight with T4 DNA ligase to yield pMG27. Plasmid pMG27 was partially digested with NdeI, filled in, and ligated to yield pMG27N. Plasmid pMG27N has a single NdeI site encompassing an ATG initiation codon located 8 bp downstream of the Cl, ribosome binding site.
Bacterial growth, induction, and pulse-labeling. The pSKcHras, pSKT24, pSKT24t1, and pSKT24t2 expression plasmids were maintained in cI+ hosts. For expression the plasmids were transferred into E. coli K-12 N5151 or AR58 (J. Auerbach, unpublished data) carrying the c1857(Ts) mutation (24) . The cells were grown at 32°C to an optical density at 650 nm of 0.4 (strain N5151) or 0.6 (strain AR58) and induced by rapidly increasing the temperature to 42°C.
Pulse-labeling with [35S]methionine was performed as previously described (24) . At the indicated times after induction, 200-,ul samples of the culture were pulse-labeled with 20 ,uCi of [35S]methionine for 45 s, and the cell lysates were analyzed by sodium dodecyl sulfate (SDS)-PAGE (15) . Largescale fermentations (4 to 10 liters) were performed as previously described (24) . Cell pellets were stored at -70°C. Purification of ras proteins. Induced AR58 cells containing the normal, T24, or carboxyl-terminal truncated T24 proteins were resuspended in 7 volumes of buffer X (20 mM Tris-acetate [pH 7.5], 0.1 mM EDTA, 1 mM MgCl2, 0.1 mM ATP, 1.0 mM 2-mercaptoethanol [2-ME]) at 0°C and lysozyme was added to a concentration of 0.2 mg/ml. After 30 min, phenylmethylsulfonyl fluoride (0.2 M in methanol) was added (final concentration, 1 mM), and the viscosity of the sample was reduced by sonication. Cell debris was FIG. 1. Construction of vectors for the expression of the full-length normal and T24 mutant H-ras proteins. For the construction of pSKT24 a synthetic, double-stranded oligonucleotide encoding amino acid residues 6 to 10 of H-ras was ligated into pUC9 between the HindIlI and Narl sites. The resultant plasmid, pUC49, was cleaved with Narl and ligated with a 900-bp NarI fragment isolated from the T24 ras cDNA plasmid pPPS22 to give pUC59. To complete the reconstruction of the amino terminus, a second synthetic oligonucleotide was introduced into pUC59 at the HindIll site. The oligomer bearing the Ndel half site was first phosphorylated with T4 DNA kinase before annealing with its complementing strand. This singly phosphorylated, double-strand oligonucleotide was ligated with HindIll-cleaved pUC59. Digestion of the resultant plasmid, pUC69, with Ndel and Sall gave an 800-bp fragment containing the complete amino acid and 3' untranslated sequences of the T24 ras allele. This fragment was inserted into pMG27N between the corresponding sites to yield pSKT24. The amino-terminal protein coding sequence and vector-insert boundary were verified by Maxam-Gilbert DNA sequencing. For the construction of pSKcHras the normal ras cDNA clone pPPS3 was digested with Narl, and the 900-bp fragment encoding all but the initial 10 amino acids was isolated. Similarly, pUC69 was cleaved with Narl, and the large vector fragment containing the initial 10 ras codons was isolated. Ligation of these two Narl fragments yielded plasmid pUC69wt. The complete normal ras coding sequence was excised on an NdeI-SaIl fragment and ligated into the corresponding sites of pM627N to yield the expression vector pSKcHras. The construction of the human ras cDNA plasmids pPPS3 and pPPS22 and the pMG27N expression vector is described in the text. VOL. 5, 1985 on November 12, 2012 by MAIN LIBRARY http://mcb.asm.org/ Downloaded from removed by centrifugation at 37,000 x g for 30 min, and ammonium sulfate was added to the supernatant to 60% saturation. The ammonium sulfate pellet was collected by centrifugation, dissolved in buffer X, and applied to an AcA 34 column. Fractions containing ras protein, identified by protein blotting and GTP binding assays, were pooled and applied to a DEAE-Sephacel column equilibrated with buffer X containing 20 mM NaCl. The column was eluted with a linear 20 to 300 mM NaCl gradient in buffer X. The ras proteins eluted at 170 to 200 mM NaCl. With judicious pooling of the AcA and DEAE column fractions, the normal, T24, and C-terminal truncated ras proteins were obtained at about 90% homogeneity in about a 20% overall yield. The actual amount of the pure proteins recovered per gram of packed frozen cells was about 0.3 mg for the T24 and carboxyl-terminal truncated T24 proteins and about 0.15 for the normal product. Protein concentrations were measured with the Bio-Rad protein assay, using blue dye reagent and bovine serum albumin (BSA) as the standard (2). The molecular concentration of one highly purified sample (>95%) was determined by quantitative amino acid analysis, and the concentrations of the other preparations were then estimated from their relative purity as measured by SDS-PAGE. Amino acid sequencing of the normal and T24 proteins verified their predicted sequence through the initial 15 amino-terminal residues. For purification of the aminoterminal truncated H-ras protein, induced cells were lysed and centrifuged as above. Essentially all of this ras protein was found in the pellet. The pellet was successively extracted with buffer B (50 mM Tris-hydrochloride [pH 8], 2 mM EDTA, 0.1 mM dithiothreitol, 5% glycerol) containing 0.05% deoxycholate, 1.5 M NaCl, and then 1.5% octylglucopyranoside. The T241 protein was then solubilized with 4 (11) . The protein sample was added to the assay solution and incubated for 20 min. The primary antibody (rabbit anti-T24t1, prebled antiserum or rat monoclonal 259) was added for 30 min, followed by rabbit anti-rat IgG (in assays with the monoclonal antibody) for 30 min and then by protein A-Sepharose beads for 1 h with mixing. The beads were then washed extensively with buffer A, eluted by heating at 95°C for 5 min with gel loading buffer, and centrifuged. A portion of the eluted sample was counted in a scintillation counter.
(ii) GTP binding on a protein blot. After SDS-PAGE and electrotransfer as described above, the protein blots were incubated successively in the following solutions with gentle agitation: 3% BSA in phosphate-buffered saline containing 5 mM sodium PP, for 1 h at 25°C, twice in buffer A for 15 min at 4°C, and finally in buffer A containing 5 mM [ox-32P]dGTP (2.7 Ci/mmol) and 1 mM sodium PP, for 30 min at 4°C. Monoclonal antibody 259 was added for 30 min at 4°C, followed by the addition of rabbit anti-rat IgG for 20 min at 4°C. Then the blot was washed five times with buffer A containing 1 mM sodium PP, at 4°C.
(iii) Filter binding. The normal and T24 protein samples were incubated with [a-32P]GTP in buffer A containing 0.12 M ammonium sulfate at 25°C. Samples of these reactions were added to 2 ml of buffer A at 4°C containing 10 p,g of BSA per ml. The samples were filtered through nitrocellulose (pore size, 0.45 ,um) and washed with 20 ml of buffer A. The filters were counted in a scintillation counter at settings for Cerenkov radiation.
Antibody preparation. Polyclonal antibody directed against the purified amino-terminal truncated protein (T24t,) was prepared in New Zealand White rabbits. Rabbits were injected subscapularly at 10-day intervals, and the antibody was titrated by an enzyme-linked immunosorbent assay procedure with goat anti-rabbit IgG conjugated to horseradish peroxidase.
RESULTS
Vector constructions for the expression of normal and mutant ras proteins. The constructions of the plasmid vectors for the expression of the authentic normal (pSKcHras) and T24 variant (pSKT24) human H-ras gene products are diagrammed in Fig. 1 . The basic expression vector, pOT1 (5) , is a derivative of pAS1 (24) and uses transcriptional and translational control elements derived from phage lambda to regulate expression of inserted foreign genes. We further modified the pOT1 vector by deleting three of its four NdeI restriction sites (Fig. 1) . The resulting vector, pMG27N, retains a single NdeI site which overlaps the translation initiation codon (CATATG) provided on the vector. Plasmids containing the complete protein coding sequences of the human normal (pPPS3) and T24 (pPPS22) H-ras genes in a cDNA configuration were constructed by splicing together cDNA (6) and genomic H-ras (38) clones as described above (Fig. 1) .
To introduce the complete T24 ras coding sequence into pMG27N at the unique NdeI site, we first reconstructed the N-terminus of the T24 ras cDNA with synthetic oligonucleotide linkers. Two overlapping linkers were used to replace the first 28 bp of the ras gene sequence and to position an NdeI site at the initiation codon (Fig. 1) . The linker sequences also introduced nucleotide changes into the ras coding sequence; however, none of these changes altered the amino acid sequence encoded by the gene. The nucleotide changes created codons which were more fre- 22 codons was isolated. The expression vector pOT1 was digested with BamHI and subsequently treated with mung bean nuclease to create a flush end terminating with ATG. The vector was cleaved with Sall and ligated with the 800-bp ras fragment to yield the pSKT24t, expression plasmid. The ras coding sequence is deleted in frame between codons 1 and 23. B. For the construction of pSKT24t2 the activatec ras plasmid pUC69 was quently used by E. coli and also introduced a unique HindIII restriction site at position 13 in the T24 ras gene sequence. The remainder of the ras coding sequence, extending from a unique NarI site, was obtained from the T24 cDNA plasmid pPPS22. The reconstructed ras coding sequence was excised on an NdeI-SalI DNA fragment and inserted into the corresponding NdeI and SalI sites on pMG27N. Direct DNA sequencing verified that the synthetic 5' terminus of the gene and the junctions of the insert on the final expression vector, pSKT24, were correct. The corresponding plasmid containing the wild-type H-ras allele, pSKcHras, was made by exchanging a DNA segment, which included the T24 mutation, with the same DNA segment obtained from plasmid pPPS3 containing the normal ras cDNA sequence (Fig. 1) . The final ras expression vectors are thus identical, except for a sequence difference at position +34 (guanine versus thymine, glycine in wild type versus valine in T24 at codon 12) of the ras coding sequence. We also constructed vectors for the expression of an amino-terminal truncated and a carboxyl-terminal truncated derivative of the T24 ras gene.
Plasmid pSKT24t, encoding the amino-terminal deletion was constructed by inserting a PvuII-SalI fragment from pPPS22 directly into the pOT1 expression vector between the BamHI and Sall sites ( Fig. 2A) . The BamHI site of the vector was first blunt ended with mung bean nuclease (24), thereby allowing direct fusion of the PvuII end of the fragment insert. This fusion places codon 23 of ras in frame with the ATG initiation codon provided on the vector and thus leads to expression of a variant ras protein deleted between amino acid residues 1 and 23 (T24g,). Vector pSKT24t2 expressing the carboxyl-terminal deletion was constructed by first introducing a linker encoding a TGA termination signal after amino acid residue 166 in pUC69. This ras sequence, deleted of 23 C-terminal residues, was then transferred to the NdeI-SaII window of the pMG27N expression vector (Fig.   2B ). Expression of wild-type and variant ras proteins. The ras expression plasmids pSKcHras, pSKT24, pSKT24t,, and pSKT24t2, as well as the control vector pMG27N, were transfected into E. coli lysogens, which carry a defective prophage encoding a temperature-sensitive repressor (cl857).
Cultures were grown at 32°C and induced at 42°C, and protein expression was initially examined by pulse-labeling with [35S]methionine. Each of the ras vectors selectively induced the synthesis of a prominent labeled 20 to 22kilodalton (kDa) protein, which was absent in cultures containing the control vector (Fig. 3 , results for pSKT24t2 are not shown). The induced products were identified directly as ras proteins by an immunoblot (i.e., Western) analysis with a monoclonal antibody (11) developed against the viral H-ras protein. Total induced bacterial lysates were fractionated by SDS-PAGE and transferred electrophoretically to nitrocellulose paper. The Western analysis (Fig. 4 4 . Identification of ras proteins with anti-vH-ras monoclonal antibody. At the indicated times, the optical density at 650 nm of cultures of N5151 containing the designated plasmids was measured, and 1-ml samples were removed and centrifuged at 10,000 x g for 1 min. The cell pellets were solubilized, and an equivalent of 0.006 unit (optical density at 650 nm) of cells was fractionated by SDS-PAGE and on a 15% gel and assayed for ras protein by an immunoblot procedure (see the text). The purified T24 protein (40 ng) was included as a reference. The processed blot was exposed to X-ray film for 8 days at -70°C with an intensifying screen. kd, kDa.
To examine the stability of the various ras gene products in E. coli, we carried out pulse-chase-labeling experiments. Induced cultures were pulse-labeled with [35S]methionine for 1 min and then chased with excess unlabeled methionine in the presence of chloramphenicol. Samples were examined at various times after the chase. The results (data not shown) indicate that the four different ras proteins have similar stabilities in E. coli with a half-life of approximately 10 to 15 min. We examined several different E. coli K-12 strains for their ability to synthesize and stabilize the ras proteins, and all were found to exhibit similar levels of expression.
The efficient expression of all four ras gene constructs resulted in the accumulation of sufficient protein to enable the development of a simple and rapid protocol for ras purification (detailed above). Of note, upon lysis the wildtype, T24, and T24t2 ras proteins were found exclusively in the soluble portion of the cell extract. Curiously, the fulllength ras proteins produced in other E. coli expression systems are insoluble and require the use of strong denaturants to obtain them in soluble form (14) . Only our N-terminal truncated ras derivative, T24tj, was found to be insoluble upon initial cell lysis and required the use of denaturants for its solubilization. However, upon removal of the urea by dialysis, this truncated derivative remains soluble (see above). A gel profile of the purified normal, T24 and T24tj, proteins is shown in Fig. 5 . The difference in the mobilities of the purified normal and T24 proteins in SDS-denaturing gels is consistent with previous comparisons of similar proteins produced in mammalian cells (11, 20, 30) . Thus, this altered mobility is a consequence of primary sequence rather than differential modification in mammalian cells. Corresponding results were reported recently by Lacal et al. (14) .
We also note that the mobility of T24t, is similar to that of T24, although the former is presumably deleted of 22 amino-terminal residues (Fig. 3) . We have not directly deter-mined the amino or carboxy terminus of the T24t1 protein, but based on our experience with other proteins expressed from pAS-1 or derivative vectors, we think it unlikely that the T24t1 differs from its predicted primary sequence. We thus presume that the aberrant migration of T24t, results from conformational properties in SDS.
Guanine nucleotide binding of the wild-type and T24 ras proteins. One well-characterized biochemical property of the ras proteins is their ability to selectively bind certain guanine nucleotides (e.g., GTP, GDP, and dGTP). We have utilized three different procedures to assess the guanine binding properties of our bacterially produced ras proteins. First, we developed a simple qualitative ligand binding assay which can be applied either to complex protein mixtures such as total E. coli cell lysates or to purified preparations of the ras proteins. In addition, this assay allows analysis of both soluble and insoluble protein preparations. The protein(s) was resolved by SDS-PAGE, transferred to nitrocellulose, and then incubated with [ox-32P]dGTP and the ras antibody (see above for details). Both the wild-type and T24 proteins, in whole cell extracts or as purified proteins, bound dGTP ( Fig. 6A and B) .
The second assay uses an immunoprecipitation procedure (27) to examine ras-related guanine nucleotide binding. Soluble protein extracts were prepared from induced cultures producing the wild-type and T24 proteins. Portions of these extracts were incubated with [3H]GDP or [a-32PJdGTP and subsequently immunoprecipitated with antibody and protein A-Sepharose (see above). The results (Table 1) indicate that both the normal and T24 proteins exhibit GDP-dGTP binding. This binding was competed selectively by GTP and not by ATP. In this assay only about 10 to 20% of our ras protein exhibited binding; however, this does not reflect saturation values and thus is only a minimum estimate of binding efficiency.
Our ability to purify milligram quantities of both the wild-type and T24 proteins allowed us to accurately measure GTP binding by a nitrocellulose-filter retention assay (see above). We compare the binding kinetics of these two proteins by this assay (Fig. 7) . The results show that the T24 protein exhibits a two-to threefold-slower initial rate of binding than does the normal p21, although both proteins Fig. 4 (0.06 unit [optical density at 650 nm] of cell culture) were electrophoresed on a 15% acrylamide gel, transferred to nitrocellulose, and assayed for [ct-32P]dGTP binding as detailed in the text. The film was exposed at -70°C with an intensifying screen for 7 days. B. About 0.4 ,ug of the purified normal, T24, and T24t, proteins were processed as described for panel A. The film was exposed for 3 days. kd, kDa. attain equivalent equilibrium binding. This difference between the two proteins indicates that the substitution of valine at position 12 causes a subtle alteration of the GTP binding site. The amount of GTP bound was about 0.7 mol/mol of p21 (the protein concentration was determined by quantitative amino acid analysis). This value represents saturation binding since comparable results were obtained even at a 20-fold-lower GTP concentration (not shown). In 20-,ul portions were removed at the indicated times and assayed for GTP bound to protein by filtration through nitrocellulose (see the text). The molar concentration of the ras proteins was estimated as described in the protein purification section of the text. other assays we have determined that the efficiency of retention on nitrocellulose is only 70 to 80% (35) . Thus, most (if not all) of our purified wild-type and T24 mutant ras proteins are capable of guanine nucleotide binding.
Guanine nucleotide binding of the ras truncates. Since the N-terminal truncated protein is expressed in an insoluble form, we assessed its GTP binding activity only by the protein blot-ligand binding assay. This assay allows us to compare directly the qualitative GTP binding of this N-terminal truncate with the full-length forms of ras because whole cell extracts are examined after identical treatment. The T24t1 protein showed no binding activity under conditions in which both the full-length normal and T24 products did bind GTP (Fig. 6) .
In contrast, the C-terminal truncated ras derivative, T24t2, does retain its GTP binding activity. As mneasured by the filter binding assay (Fig. 7) , the kinetics of binding are similar to those of the full-length T24 product; however, the overall extent of binding is significantly reduced. This nonstoichiometric binding was not altered by increasing the GTP concentration fivefold (not shown), suggesting that only a fraction of our purified protein preparation is active. Nonetheless, these results suggest that the carboxyl-terminal 23 amino acids of ras are not essential for its GTP binding ability.
DISCUSSION
We described the construction of E. coli expression vectors which encode the authentic wild-type human H-ras protein, its T24 variant, and two differeht truncated forms of the T24 protein. One of the T24 truncated proteins, T24tj, was deleted between residues 1 and 23 at the amino terminus, whereas the other truncated protein, T,24t2, was deleted for 23 C-terminal residues. To precisely irltVoduce the wildtype and T24 cDNA sequences iAto the expression vector, the 5' end of the ras gene was reconstructed with synthetic linkers. In doing so, we inserted a unique HindIll restriction site at codon positions 4 and 5 in the human gene without altering the amino acid coding sequence. Creation of this restriction site provides a new entry site into the N-terminal sequence of the human gene which has been useful for making additional gene alterations. In addition, we made several codon changes within this region of the gene to introduce codons more frequently used in E. coli. The four different ras gene constructs were shown to express efficiently in E. coli, and the ras products accumulated to levels ranging from 1% (cH-ras) to 5% (T24t1) of total cellular protein. Pulse-chase analyses indicated approximately equivalent half-lives for these proteins, although these assays would not readily detect a 1.5-to 2-fold difference. Thus, the efficiency of transcription or translation, or both, of these plasmids probably differs slightly. The induced protein products were shown to be ras related by immunoblot analysis with a monoclonal antibody raised against the authentic mammal-derived p21 protein (Fig. 4) .
The wild-type, T24, and T24t2 (C-terminal truncated) proteins were produced in soluble form in E. coli and were purified to homogeneity without the use of chaotropic agents. Only the T24t1 (N-terminal truncated) protein was found to be insoluble in crude cell lysates and required treatment with urea for its initial solubilization. This report constitutes the first description of an extensive purification of nonfused ras proteins from bacteria without denaturation of the protein.
We point this out to emphasize our concern that the biochemical, physical, and biological characteristics of proteins which are fused to other proteins, denatured during their isolation, or both may not accurately reflect the properties of the native protein. As evidenced above, this does not appear to be the case with the proteins described here.
We used our purified ras protein preparations to characterize certain biochemical parameters, as well as biological activities, of these E. coli-synthesized molecules. In this report, we described the guanine nucleotide binding capabilities of these proteins. We demonstrated (by several different assay systems) that the full-length ras wild-type and T24 variant proteins appropriately bind certain guanine nucleotides and that the stoichiometry of nucleotide binding was essentially equimolar. This quantitative assessment of nucleotide binding was made possible only because of our ability to obtain these proteins in a sufficient quantity and in pure enough form to assay by standard nitrocellulose filter binding techniques. Moreover, we found that the C-terminal truncated ras protein retained its ability to bind GTP, although the extent of binding was reduced. Apparently, the C-terminal 23 anlino acid residues are not a crucial part of the nucleotide binding site. This C-terminal truncate, however, has lost its transforming ability (unpublished data). Willumsen et al. (42) have shown that mutations in the C-terminal portion of ras dramatically reduce its transforming ability and result in the inability of ras to localize properly to the inner cell membrane. Our results are consistent with these conclusions and further suggest that C-terminal altered molecules will retain their nucleotide binding capabilities. Ih contrast to the results obtained with the C-terminal truncate, we found that the N-terminal truncate MoL. CELL. IBIOL.
on November 12, 2012 by MAIN LIBRARY http://mcb.asm.org/ Downloaded from was completely deficient in nucleotide binding. Since this protein was insoluble upon initial lysis of the cells, our conclusion is based only on comparing its guanine binding ability to that of the other three ras proteins by the qualitative Transblot ligand binding assay (Fig. 6 ). The inability of this derivative to bind nucleotide is consistent with protein modeling studies (22, 40) which implicate the region around amino acid 12 as part of the nucleotide binding site.
It recently was reported (35) that the normal ras protein, synthesized and purified as described in this report, has an intrinsic GTPase activity which yields GDP and Pi. In contrast, the T24 transforming derivative was markedly deficient in this activity. Presumably, this defect is responsible for its transforming properties. Preliminary data suggest that the C-terminal truncate, described here, exhibits GTPase properties similar to those found for the full-length T24 derivative. This result further suggests that the carboxyl end of ras does not play a critical role in either GTP binding or GTP catalysis.
It also has been demonstrated that E. coli-produced and -purified ras proteins exhibit authentic biological activities when they are introduced into mammalian cells (8) . The T24 oncogenic form of ras caused rapid morphological changes and induced cell proliferation when microinjected into quiescent, confluent NRK, REF52, and NIH 3T3 rodent cells. In contrast, the wild-type protein exhibited little, if any, effect on these cells. We conclude that the ras proteins synthesized in E. coli are appropriate substrates for studying both the biochemical and biological activities of these molecules. We have thus undertaken the purification of sufficient pure protein for crystallographic analysis of both the wild-type and T24 variant proteins.
